Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03640897
Other study ID # LiNiRash
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2, 2018
Est. completion date March 18, 2019

Study information

Verified date April 2019
Source Laboratoires Gilbert
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Result of immaturity of the skin and factors promoting maceration and mechanical interactions, Irritant diaper dermatitis (IDD) can manifest as early as the third week of life. IDD is a form of contact dermatitis and is the most common inflammatory dermatitis of the diaper area infants. This dermatitis is very common amongst first year of life.

The IDD is characterized by erythema on the convex surfaces with the skin folds spared (W-shaped erythema) and it can cause considerable pain and stress for infants and can be troublesome for their caregivers.

The development of IDD is multifactorial. The critical step in the development of IDD is the occlusion of the skin under the diaper. The skin in the diaper area is predisposed to irritation by the presence of urine, stool, friction on the skin and presence of a high skin pH (potential Hydrogen).

At the cellular level, there is a gradual disorganization of the lipid layers and later an attack of keratinocytes. Clinically, maceration is followed by an inflammatory reaction.

Hence, infrequent diaper changes create overhydration and maceration of the stratum corneum, which makes the skin more sensitive to friction; this may interfere with the protective barrier function, allowing for the exposure of the lower layers to irritants (mechanical, chemical and infectious).

The removal of maceration and the reduction of friction are the key to prevention. But it is recommended to respect preventive measures, in order to preserve the normal skin condition over the long term. Special care procedures are required to ensure healthy development and to protect the skin from irritation and inflammation, as well as a sense of well-being. Although use of appropriately formulated cleansers and emollients can help maintain the epidermal skin barrier in the diaper region, good hygiene and adequate protection are necessary to prevent skin barrier breakdown, rash and infection. The prevention of IDD includes frequent diaper changing, parent education and cleaning.

LiNiRASH is a monocentric, prospective, randomized, comparator controlled study conducted under paediatric control. 132 infants will be followed in this study for 4 weeks during which their parents will use a specific cleaning method: water and cotton pads or wipes or liniment. The objective of this study is to compare the performance and safety of this 3 cleaning methods on the prevention of infant diaper rash.


Recruitment information / eligibility

Status Completed
Enrollment 133
Est. completion date March 18, 2019
Est. primary completion date March 18, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Months to 36 Months
Eligibility Inclusion Criteria:

- Aged 3 - 36 months, in good health, born at term or up to 1 month before term,

- A skin phototype I- III according to Fitzpatrick scale,

- Wearing diapers daily with at least 2 changes per day and a night port,

- For whom parents have given their written informed consent regarding its participation in this clinical investigation.

Exclusion Criteria:

- Wearing washable or pull-on diapers,

- Presenting a diaper rash (in progress),

- Presenting a cutaneous pathology known,

- Treated actually by phototherapy,

- Presenting a cow's milk protein allergy,

- Under medical treatment which may interfere with studied products and/ or skin in the 4-weeks prior to enrolment.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Liniderm
Cleaning of the diaper area with Liniderm at each diaper change during 28 days
Other:
Wipes
Cleaning of the diaper area with wipes at each diaper change during 28 days
Water
Cleaning of the diaper area with water and cotton pads at each diaper change during 28 days

Locations

Country Name City State
Poland Dermscan Gdansk

Sponsors (2)

Lead Sponsor Collaborator
Laboratoires Gilbert Slb Pharma

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of infants who had at least one episode of diaper rash Every day, in a daily log, parents/ caregivers will report the presence or not of a diaper rash.
At the end of the follow-up, the investigator must identify infant who have had at least one episode of diaper rash.
28 days
Secondary Severity of diaper rash episodes: rating Every day, parents/ caregivers will report the rating of erythema if applicable using an illustrated scale ( 4 points scale).
The rating scale is: 0 (Normal skin), 1 (Mild erythema/ pink skin), 2 (Severe erythema/ red skin) and 3 (Erythema with skin erosion).
Continuously for 28 days
Secondary Severity of diaper rash episodes: extent Every day, parents/ caregivers will report the extent of erythema if applicable using an illustrated scale ( 4 points scale).
The extent scale is: 0 (Healthy skin), 1 (On the folds/ small spread), 2 (On the convexity/ moderate spread) and 3 (Wide spread).
Continuously for 28 days
Secondary Safety of the cleaning method Every day, parents will report intolerance/ discomfort felt. Also, at each visit, the investigator will carry out a clinical examination of the diaper area; the investigator will assess the tolerance using a 4-points Likert scale.
The 4-points Likert scale is: Bad (0), Moderate (1), Good (2) or Very good (3)
Continuously for 28 days
Secondary Skin evaluation on the genital area Assessment of the skin integrity using a numeric scale (6 points) by the paediatrician at each visit.
The numeric scale is: 0 (No rash), 1 (Mild irritation or rash), 2 (Moderate irritation or rash), 3 (Considerable irritation or rash), 4 (Extreme irritation or rash) and 5 (Extreme erythema involving entire area, oozing papules, pustules erosion).
Skin colour measurements using a Chroma Meter.
0, 14 and 28 days
Secondary Paediatrician satisfaction The paediatrician's satisfaction (regarding performance) will be assessed for each infant using a 4-point Likert scale.
The 4-point Likert scale is: Bad (0), Moderate (1), Good (2) or Very good (3)
14 and 28 days
Secondary Well-being The well-being of infant will be assessed by parents at each visit. Questions will be about crying, agitation, tension and scratching (Yes/ No). 0, 14 and 28 days
Secondary Parents satisfaction The parents' satisfaction (regarding performance and safety) will be assessed using a 4-point Likert scale.
The 4-point Likert scale is: Bad (0), Moderate (1), Good (2) or Very good (3)
14 and 28 days
See also
  Status Clinical Trial Phase
Completed NCT02893501 - Infant Microbiome in Diaper Rash N/A
Completed NCT05328232 - The Effect Of Olive Oil on Diaper Rash N/A
Completed NCT02996357 - Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence N/A
Completed NCT05427760 - Effect Of Using Oxygen On The Diaper Dermatitis In Infants N/A
Completed NCT03685929 - Histopathological Comparison Between Superficial Pressure Ulcers and Incontinence-associated Dermatitis
Completed NCT05599763 - Multicenter, National, Observational, Prospective, Real-life Study Evaluating the Performance of 2% Aqueous Eosin in Children With Diaper Rash
Completed NCT03309059 - Comparison of Barrier Products in the Prevention of Incontinence-associated Dermatitis in Hospitalized Elderly N/A
Terminated NCT02475512 - Comparison of Wash Wipes and Standard Care in the Prevention of Incontinence-associated Dermatitis in Elderly N/A
Completed NCT00702507 - Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Phase 4
Completed NCT03138057 - BM Characterization Pilot N/A
Withdrawn NCT03425851 - Diaper Distribution in Low-Income Infants N/A
Completed NCT00219466 - Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash Phase 4
Withdrawn NCT01167465 - Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis Phase 4
Completed NCT04210674 - Effects of Argan Spinosa Oil in the Treatment of Diaper Dermatitis in Infants and Toddlers N/A
Terminated NCT02299206 - CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants N/A
Completed NCT06015217 - A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash Phase 4
Withdrawn NCT05471180 - Adjuvant Effect of Photobiomodulation in the Treatment of Incontinence-associated Dermatitis in Adults N/A
Completed NCT05892081 - Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit Phase 4